This meta-analysis is to investigate and analyze the latest RCT evidence regarding the efficacy and safety of PD-L1 inhibitors alone with those of chemotherapy for treating advanced NSCLC. This evidence concerns the gene CD274 and non-small cell lung carcinoma.